Synergy between the antinociceptive effects of morphine and NSAIDs

H. F. Miranda, E. Silva, G. Pinardi

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The intraperitoneal administration of morphine, diclofenac, ketoprofen, meloxicam, metamizol, paracetamol and piroxicam induced dose-dependent antinociception in mice tested with the acetic acid writhing test. The isobolographic analysis of the simultaneous intraperitoneal administration of fractions of the ED50's of morphine with each nonsteroidal anti-inflammatory drug (NSAID) demonstrated the existence of a supra-additive interaction (synergy). The selective antagonist of μ-opioid receptors naltrexone partially reversed the supra-additive interactions to additive interactions; however, the combinations of morphine/metamizol and morphine/paracetamol were completely antagonized, resulting in subadditive interactions. The selective antagonist of δ-opioid receptors naltrindole failed to significantly attenuate the combinations of morphine with ketoprofen, meloxicam and piroxicam, but decreased the activity of the combinations of morphine with diclofenac, metamizol and paracetamol, transforming the interactions from supra-additive to additive. Nor-binaltorphimine was used to evaluate the involvement of κ-opioid receptors. Nor-binaltorphimine did not modify the supra-additive interaction of morphine and NSAIDs and the additive interaction of the co-administration of morphine and metamizol. The synergy between morphine and NSAIDs could be related to different pathways of pain transmission, probably related to the different intracellular signal transduction mechanisms of action of opioid and non-opioid agents.

Original languageEnglish
Pages (from-to)331-338
Number of pages8
JournalCanadian Journal of Physiology and Pharmacology
Volume82
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

Non-Steroidal Anti-Inflammatory Agents
Morphine
Dipyrone
meloxicam
Acetaminophen
Piroxicam
Ketoprofen
naltrindole
Narcotic Antagonists
Diclofenac
Naltrexone
Opioid Receptors
Acetic Acid
Opioid Analgesics
Signal Transduction
Anti-Inflammatory Agents
Pain

Keywords

  • Antinociception
  • Isobolographic analysis
  • Morphine
  • NSAIDs
  • Synergy
  • Writhing test

ASJC Scopus subject areas

  • Medicine(all)
  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Miranda, H. F. ; Silva, E. ; Pinardi, G. / Synergy between the antinociceptive effects of morphine and NSAIDs. In: Canadian Journal of Physiology and Pharmacology. 2004 ; Vol. 82, No. 5. pp. 331-338.
@article{121b34c11f4a4aaaacb130edb0721d1a,
title = "Synergy between the antinociceptive effects of morphine and NSAIDs",
abstract = "The intraperitoneal administration of morphine, diclofenac, ketoprofen, meloxicam, metamizol, paracetamol and piroxicam induced dose-dependent antinociception in mice tested with the acetic acid writhing test. The isobolographic analysis of the simultaneous intraperitoneal administration of fractions of the ED50's of morphine with each nonsteroidal anti-inflammatory drug (NSAID) demonstrated the existence of a supra-additive interaction (synergy). The selective antagonist of μ-opioid receptors naltrexone partially reversed the supra-additive interactions to additive interactions; however, the combinations of morphine/metamizol and morphine/paracetamol were completely antagonized, resulting in subadditive interactions. The selective antagonist of δ-opioid receptors naltrindole failed to significantly attenuate the combinations of morphine with ketoprofen, meloxicam and piroxicam, but decreased the activity of the combinations of morphine with diclofenac, metamizol and paracetamol, transforming the interactions from supra-additive to additive. Nor-binaltorphimine was used to evaluate the involvement of κ-opioid receptors. Nor-binaltorphimine did not modify the supra-additive interaction of morphine and NSAIDs and the additive interaction of the co-administration of morphine and metamizol. The synergy between morphine and NSAIDs could be related to different pathways of pain transmission, probably related to the different intracellular signal transduction mechanisms of action of opioid and non-opioid agents.",
keywords = "Antinociception, Isobolographic analysis, Morphine, NSAIDs, Synergy, Writhing test",
author = "Miranda, {H. F.} and E. Silva and G. Pinardi",
year = "2004",
month = "5",
doi = "10.1139/y04-027",
language = "English",
volume = "82",
pages = "331--338",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "5",

}

Synergy between the antinociceptive effects of morphine and NSAIDs. / Miranda, H. F.; Silva, E.; Pinardi, G.

In: Canadian Journal of Physiology and Pharmacology, Vol. 82, No. 5, 05.2004, p. 331-338.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synergy between the antinociceptive effects of morphine and NSAIDs

AU - Miranda, H. F.

AU - Silva, E.

AU - Pinardi, G.

PY - 2004/5

Y1 - 2004/5

N2 - The intraperitoneal administration of morphine, diclofenac, ketoprofen, meloxicam, metamizol, paracetamol and piroxicam induced dose-dependent antinociception in mice tested with the acetic acid writhing test. The isobolographic analysis of the simultaneous intraperitoneal administration of fractions of the ED50's of morphine with each nonsteroidal anti-inflammatory drug (NSAID) demonstrated the existence of a supra-additive interaction (synergy). The selective antagonist of μ-opioid receptors naltrexone partially reversed the supra-additive interactions to additive interactions; however, the combinations of morphine/metamizol and morphine/paracetamol were completely antagonized, resulting in subadditive interactions. The selective antagonist of δ-opioid receptors naltrindole failed to significantly attenuate the combinations of morphine with ketoprofen, meloxicam and piroxicam, but decreased the activity of the combinations of morphine with diclofenac, metamizol and paracetamol, transforming the interactions from supra-additive to additive. Nor-binaltorphimine was used to evaluate the involvement of κ-opioid receptors. Nor-binaltorphimine did not modify the supra-additive interaction of morphine and NSAIDs and the additive interaction of the co-administration of morphine and metamizol. The synergy between morphine and NSAIDs could be related to different pathways of pain transmission, probably related to the different intracellular signal transduction mechanisms of action of opioid and non-opioid agents.

AB - The intraperitoneal administration of morphine, diclofenac, ketoprofen, meloxicam, metamizol, paracetamol and piroxicam induced dose-dependent antinociception in mice tested with the acetic acid writhing test. The isobolographic analysis of the simultaneous intraperitoneal administration of fractions of the ED50's of morphine with each nonsteroidal anti-inflammatory drug (NSAID) demonstrated the existence of a supra-additive interaction (synergy). The selective antagonist of μ-opioid receptors naltrexone partially reversed the supra-additive interactions to additive interactions; however, the combinations of morphine/metamizol and morphine/paracetamol were completely antagonized, resulting in subadditive interactions. The selective antagonist of δ-opioid receptors naltrindole failed to significantly attenuate the combinations of morphine with ketoprofen, meloxicam and piroxicam, but decreased the activity of the combinations of morphine with diclofenac, metamizol and paracetamol, transforming the interactions from supra-additive to additive. Nor-binaltorphimine was used to evaluate the involvement of κ-opioid receptors. Nor-binaltorphimine did not modify the supra-additive interaction of morphine and NSAIDs and the additive interaction of the co-administration of morphine and metamizol. The synergy between morphine and NSAIDs could be related to different pathways of pain transmission, probably related to the different intracellular signal transduction mechanisms of action of opioid and non-opioid agents.

KW - Antinociception

KW - Isobolographic analysis

KW - Morphine

KW - NSAIDs

KW - Synergy

KW - Writhing test

UR - http://www.scopus.com/inward/record.url?scp=4143121262&partnerID=8YFLogxK

U2 - 10.1139/y04-027

DO - 10.1139/y04-027

M3 - Article

C2 - 15213733

AN - SCOPUS:4143121262

VL - 82

SP - 331

EP - 338

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 5

ER -